Searched over 200M research papers for "cholesterol vitamin"
10 papers analyzed
Some studies suggest that vitamins C and D can reduce LDL cholesterol and triglyceride levels, while other studies indicate that vitamin D supplementation does not significantly affect cholesterol biomarkers or improve cardiovascular outcomes.
20 papers analyzed
Vitamin C has been shown to significantly reduce low-density lipoprotein (LDL) cholesterol levels. A meta-analysis of 13 randomized controlled trials found that supplementation with at least 500 mg/day of vitamin C for a minimum of four weeks resulted in a significant decrease in serum LDL cholesterol by an average of 7.9 mg/dL. This suggests that vitamin C can be an effective therapeutic option for lowering LDL cholesterol in patients with hypercholesterolemia.
In addition to its effects on LDL cholesterol, vitamin C supplementation also significantly reduces triglyceride levels. The same meta-analysis reported a reduction in triglycerides by 20.1 mg/dL. This dual effect on LDL cholesterol and triglycerides highlights the potential of vitamin C in managing lipid profiles.
Vitamin D supplementation has been studied extensively for its effects on serum lipid profiles. A systematic review and meta-analysis of 41 randomized controlled trials found that vitamin D supplementation led to modest reductions in total cholesterol and LDL cholesterol levels. Specifically, the standardized mean differences (SMDs) for total cholesterol and LDL cholesterol were -0.17 and -0.12, respectively. However, the effects on high-density lipoprotein (HDL) cholesterol and triglycerides were not significant.
The mechanisms by which vitamin D influences cholesterol metabolism are complex. One study suggested that vitamin D deficiency is associated with higher cholesterol levels due to reduced vitamin D receptor activity, which affects the Insig-2/SREBP-2 pathway involved in cholesterol biosynthesis. Another study indicated that vitamin D supplementation did not significantly affect surrogate biomarkers of cholesterol absorption or endogenous synthesis in patients with type 2 diabetes.
Vitamin E, particularly when combined with caloric restriction, has been shown to influence cholesterol metabolism. Research indicates that vitamin E supplementation can increase LDL cholesterol levels by upregulating the expression of genes involved in cholesterol metabolism, such as Hmgcr and LDLr. This suggests that while vitamin E has antioxidant properties, its effects on cholesterol may be more complex and context-dependent.
Vitamin B12 deficiency has been linked to increased cholesterol biosynthesis. Clinical studies have shown that low vitamin B12 status is associated with higher total cholesterol and LDL cholesterol levels. The underlying mechanism involves the modulation of the methylation of SREBF1 and LDLR genes, which are key regulators of cholesterol biosynthesis.
Calcium supplementation, with or without vitamin D, has been found to have beneficial effects on blood lipid profiles. A meta-analysis of 22 trials reported that calcium supplements significantly reduced LDL cholesterol levels and increased HDL cholesterol levels. These findings suggest that calcium, possibly in combination with vitamin D, can be a useful non-pharmaceutical strategy for cholesterol management.
The impact of various vitamins on cholesterol levels is multifaceted and varies depending on the specific vitamin and context. Vitamin C and D supplementation have shown promise in reducing LDL cholesterol and triglycerides, while the effects of vitamin E and B12 are more complex and require further investigation. Calcium supplementation, particularly when combined with vitamin D, also appears to offer benefits for lipid profiles. These findings underscore the potential of vitamins as part of a comprehensive approach to managing cholesterol and reducing cardiovascular risk.
Most relevant research papers on this topic